Literature DB >> 28070573

Nanoparticle delivery of Wnt-1 siRNA enhances photodynamic therapy by inhibiting epithelial-mesenchymal transition for oral cancer.

Chuan Ma1, Leilei Shi2, Yu Huang2, Lingyue Shen1, Hao Peng1, Xinyuan Zhu2, Guoyu Zhou1.   

Abstract

Activation of the epithelial to mesenchymal transition (EMT) in photodynamic therapy (PDT) can lead to the recurrence and progression of tumors. To enhance the effects of PDT, it is essential to inhibit the Wnt/β-catenin signaling pathway involved in EMT progression. Herein, we used polyethylene glycol-polyethyleneimine-chlorin e6 (PEG-PEI-Ce6) nanoparticles to efficiently deliver Wnt-1 small interfering RNA (siRNA) to the cytoplasm of KB cells (oral squamous cell carcinoma) that were subjected to PDT. Wnt-1 siRNA effectively inhibited the Wnt/β-catenin signaling pathway, reducing the expression of Wnt-1, β-catenin and vimentin that are crucial to the EMT. Combined with Wnt-1 siRNA, PEG-PEI-Ce6 nanoparticle mediated PDT inhibited cell growth and enhanced the cancer cell killing effect remarkably. Our results show the promise of combination therapy of PEG-PEI-Ce6 nanoparticles for delivery of Wnt-1 siRNA along with PDT in the treatment of oral cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28070573     DOI: 10.1039/c6bm00833j

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  17 in total

Review 1.  Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer.

Authors:  D M Valcourt; M N Dang; J Wang; E S Day
Journal:  Ann Biomed Eng       Date:  2019-11-04       Impact factor: 3.934

2.  Synthesis, Characterization of NR@SiO2/PNIPAm-co-Ppa Composite Nanogel and Study On Its Application in Photodynamic Therapy.

Authors:  Zirui Wang; Qiusheng Song; Lin Zhu; Chengyan Zhao; Haihong Ma
Journal:  J Fluoresc       Date:  2022-01-29       Impact factor: 2.217

Review 3.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

Review 4.  Current trends of targeted therapy for oral squamous cell carcinoma.

Authors:  Hongjiao Li; Yao Zhang; Mengmeng Xu; Deqin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-02       Impact factor: 4.322

Review 5.  RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.

Authors:  Smaranda Buduru; Alina-Andreea Zimta; Cristina Ciocan; Cornelia Braicu; Diana Dudea; Alexandra Iulia Irimie; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2018-06-08

6.  Enhanced anti-tumor efficacy of 5-aminolevulinic acid-gold nanoparticles-mediated photodynamic therapy in cutaneous squamous cell carcinoma cells.

Authors:  Yu-Fei Chi; Jing-Jing Qin; Zhi Li; Qin Ge; Wei-Hui Zeng
Journal:  Braz J Med Biol Res       Date:  2020-04-27       Impact factor: 2.590

7.  Efficient Delivery of Therapeutic siRNA by Fe3O4 Magnetic Nanoparticles into Oral Cancer Cells.

Authors:  Lili Jin; Qiuyu Wang; Jiayu Chen; Zixiang Wang; Hongchuan Xin; Dianbao Zhang
Journal:  Pharmaceutics       Date:  2019-11-17       Impact factor: 6.321

Review 8.  Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer.

Authors:  Alexandra Iulia Irimie; Laura Sonea; Ancuta Jurj; Nikolay Mehterov; Alina Andreea Zimta; Liviuta Budisan; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2017-06-26

Review 9.  The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas.

Authors:  Jarosław Paluszczak
Journal:  Cells       Date:  2020-03-15       Impact factor: 6.600

Review 10.  Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment.

Authors:  Marco Cordani; Raffaele Strippoli; Álvaro Somoza
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.